Challenger Ltd reveals its funds management business is firing up

Challenger Ltd (ASX:CGF) is growing strongly across its annuities and funds management business.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in annuities and funds manager Challenger Ltd (ASX: CGF) are up 3% to $12.90 in morning trade after the group released a positive trading update for the quarter ending September 3o, 2017.

The dominant market position and tailwinds supporting Challenger's annuity business are no secret and today the group reported annuity-related sales (via its Life division) up 57% over the prior corresponding period.

The Life division will remain the dominant earnings driver ahead, which is good thing given its opportunity to grow if Challenger is able to effectively manage its balance sheet risk.

Challenger aims to generate returns on its investments across multi-asset classes such as money market instruments, longer dated debt, and equity investments above the total annuity payment commitments it must meet to its customers.

As such some of its investments are funneled into the funds management businesses it also runs to help meet its liabilities and it is the growth of these funds management businesses that impressed this quarter.

In fact when I wrote 3 reasons I'd buy Challenger shares last week it was slightly remiss of me to not cover Challenger's growing funds management business, particularly as its growth is a highlight of today's update.

Its two principal asset management businesses of Fidante Partners and Challenger Investment Partners manage both equities and coupon returning debt and managed to grow funds under management 5% to $73.5 billion over the quarter.

In total the funds management business booked net inflows of $3.8 billion over the quarter and its growth as a lower risk business model than the Life business is positive. It also helps diversify risk and provides a convenient segway for the group to manage its balance sheet risk via fixed income asset investments.

The Life business for example requires more capital backing as its liabilities grow and is challenged by the search for risk-adjusted investments able to deliver returns above the income streams it must payout to annuity holders.

So far, Challenger has managed this delicate balancing act well and recently raised $500 million from Japanese life insurance and annuities partner Mitsui Sumitomo, with a commitment to invest substantially more funds from Mitsui.

Today, management reconfirmed guidance for normalised profit growth of 8%-12% over FY 2018 with a robust outlook for the years ahead given its dominant market position and Australia's mandated superannuation system.

Outlook

As I suggested last week the stock looks to offer a good mix of growth, value, and income selling for $12.49. Although it has climbed higher to $12.90 today, I expect it still offers solid total returns over a 3 to 5-year timeframe ahead.

Motley Fool contributor Tom Richardson owns shares of Challenger Limited. You can find Tom on Twitter @tommyr345 The Motley Fool Australia owns shares of Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »